INS and type 1 diabetes mellitus: The systemic lack of insulin in T1DM where the plasma insulin level is known to vary from 0 to 10 μunits/dL might lead to the increased synthesis of dermcidin (Figure 5) which could be overcome in the presence of as low as 25 μunits of insulin/dL.